Ukrainian President Volodymyr Zelenskyy expressed his concerns over the possibility of former President Donald Trump returning to the White House. He labeled Trump’s claim that he could resolve Ukraine’s war with Russia within 24 hours as “very dangerous.” Zelenskyy’s worry stems from the uncertainties surrounding Trump’s proposed peace plan and the potential ramifications it might
0 Comments
Liver cancer, specifically hepatocellular carcinoma (HCC), remains a significant challenge in the field of oncology. For over two decades, researchers have been striving to find an effective systemic therapy for patients with unresectable HCC. A recent randomized trial has shed light on the potential benefits of transarterial chemoembolization (TACE) in combination with immunotherapy. This article
0 Comments
Following a missile strike in Damascus, Tehran has vowed to carry out revenge attacks against Israel. The strike resulted in the destruction of a building used as a base for Iran’s elite Revolutionary Guards, resulting in the death of five Guards and an unspecified number of Syrian troops. Ambulances and fire trucks quickly arrived at
0 Comments
In recent years, the field of artificial intelligence (AI) has captured the attention of investors worldwide. This interest has sparked the birth of numerous AI startups across the globe, each striving to make groundbreaking advancements in the field. Now, it seems that a pair of scientists at Google DeepMind, the Alphabet AI division, are preparing
0 Comments
A recent phase II study has shown that Hepatic Arterial Infusion Pump (HAIP) chemotherapy with floxuridine has significantly improved overall survival (OS) in patients with advanced intrahepatic cholangiocarcinoma (iCCA). The study conducted by Bas Groot Koerkamp, MD, PhD, of the Erasmus MC Cancer Institute in Rotterdam, the Netherlands, reported that patients treated with HAIP chemotherapy
0 Comments